[1] |
JIANG Mengyi , LU Yanqiao , WANG Hongxia .
Research progress and clinical significance of breast cancer heterogeneity
[J]. China Oncology, 2020, 30(5): 394-400.
|
[2] |
LI Min, WEN Peng, QIAN Qiuqin, QIN Ang, ZENG Li, SHI Feng.
Clinical study of iodine-125 seeds implantation in the treatment of lymph node metastasis of radioactive iodine- refractory differentiated thyroid cancer
[J]. China Oncology, 2020, 30(2): 122-127.
|
[3] |
MU Zhuanzhuan , LI Zheng , ZHANG Xin , LIN Yansong .
The effect of empiric 131 I therapy in papillary thyroid cancer patients with pulmonary metastasis
[J]. China Oncology, 2020, 30(12): 991-995.
|
[4] |
YANG Ke, ZHENG Rong, LIN Yansong.
The interpretation of management guidelines for children with thyroid nodules and differentiated thyroid cancer: radioactive iodine therapy and new progress
[J]. China Oncology, 2019, 29(6): 401-411.
|
[5] |
ZHANG Liyang, LIU Chunhao, CAO Yue, LIU Hongfeng, GAO Weisheng, LI Xiaoyi.
Experiences of 125 cases of re-operated persistent/recurrent differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 412-417.
|
[6] |
GAO Luying, LIN Yansong, JIANG Yuxin, LI Jianchu, LI Hui, ZHANG Bo, LIU Ruyu, XI Xuehua, GAO Qiong, WANG Ying, ZHAO Ruina.
Evaluation of short-term efficacy of apatinib using cervical ultrasound and thyroglobulin in the treatment of progressive radioactive iodine-refractory differentiated thyroid cancer
[J]. China Oncology, 2019, 29(6): 418-422.
|
[7] |
SONG Juanjuan, LIU Yanqing, LIN Yansong.
Clinical analysis of short-term outcome in low-to-intermediate-risk thyroid cancer after low-dose 131I therapy
[J]. China Oncology, 2019, 29(3): 207-211.
|
[8] |
LI Hui, LIN Yansong.
Molecular imaging of nuclear medicine in differentiated thyroid cancer: current status and future direction
[J]. China Oncology, 2018, 28(7): 481-486.
|
[9] |
ZHANG Yingqiang, ZHANG Xin, WANG Chen, et al.
The value of 18F-FDG PET/CT in the evaluation of multiple lung metastatic radioactive iodinerefractory differentiated thyroid cancer after apatinib therapy
[J]. China Oncology, 2018, 28(7): 505-510.
|
[10] |
ZHANG Na, LIANG Jun, LIN Yansong.
The impact of thyroglobulin antibody on efficacy of 131I ablation in patients with papillary thyroid carcinoma
[J]. China Oncology, 2017, 27(6): 476-481.
|
[11] |
HU Houyang, LIANG Jun, ZHANG Teng, et al.
Correlation between minimal extrathyroid invasion and recurrence in differentiated thyroid cancer
[J]. China Oncology, 2017, 27(12): 946-952.
|
[12] |
DUAN Yachen, CHEN Xiaojun, WU Xiaohua.
Detection of HPV in peripheral blood and its clinical significance
[J]. China Oncology, 2017, 27(11): 908-912.
|
[13] |
LIN Yansong, WANG Chen, LI Hui, et al.
The preliminary report about the efficacy and safety evaluation of apatinib in progressive radioactive iodine-refractory differentiated thyroid cancer within 8 weeks
[J]. China Oncology, 2016, 26(9): 721-726.
|
[14] |
LI Xuena, YIN Yafu, DU Bulin, et al.
The correlation study between the glucose metabolism of 18F-FDG PET/CT incidental thyroid cancer and clinicopathologic characteristics
[J]. China Oncology, 2016, 26(6): 527-532.
|
[15] |
LIU Feng, XIE Liming, ZHANG Zhiwei, et al.
Expression of miR-124 in gastric cancer and its clinical significance
[J]. China Oncology, 2016, 26(3): 215-220.
|